Latest News and Press Releases
Want to stay updated on the latest news?
-
– ONP-002 showed no cancer-causing DNA damage – Phase II clinical trial being planned SARASOTA, Fla., Aug. 12, 2024 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a company focused on...
-
Wilmington, Delaware, United States, April 11, 2023 (GLOBE NEWSWIRE) -- According to market research by TMR, the global in vivo toxicology industry is expected to witness significant growth during...
-
London, June 23, 2020 (GLOBE NEWSWIRE) -- Safety assessment of substances is essential to determine their toxic implications on humans and the environment. Toxicology studies evaluate the substances...